Drug profile · INN
epinastine hydrochloride
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride (EPINASTINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — epinastine hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 5
- Programs
- 4
- Data quality
- 0.84
Quick answer
epinastine hydrochloride (EPINASTINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11512128
VEGF/DLL4 binding agents and uses thereof
granted -
US 11434204
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 11234967
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
granted -
US 10995071
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 10934260
Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted
Frequently asked questions
What is epinastine hydrochloride?
epinastine hydrochloride (EPINASTINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for epinastine hydrochloride?
EPINASTINE HYDROCHLORIDE is a marketed brand name for epinastine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of epinastine hydrochloride?
epinastine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.